South & Central America Nerve Repair & Regeneration Market Forecast to 2028

South & Central America Nerve Repair & Regeneration Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Neurostimulation & Neuromodulation Devices {Internal Neurostimulation Devices [Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation] and External Neurostimulation Devices [Transcutaneous Electrical Nerve Stimulation Devices, Transcranial Magnetic Stimulation Devices, Respiratory Electrical Stimulation Devices]} and Biomaterials), and Application (Neurostimulation & Neuromodulation Applications {Internal neurostimulation & neuromodulation, and External neurostimulation & neuromodulation}, and Nerve Repair & Regeneration Applications {Direct Nerve Repair/Neurorrhaphy [Epineural Repair, Perineural Repair, and Group Fascicular Repair], Nerve Grafting [Autografts, Allografts, and Xenografts], and Stem cell therapy})

Report Code : BMIRE00027559 | Region : LAMEA | Industry : Medical Device | Published Date : 01/Dec/2022

The nerve repair & regeneration market in South & Central America is expected to grow from US$ 343.17 million in 2022 to US$ 583.16 million by 2028; it is estimated to grow at a CAGR of 9.2% from 2022 to 2028.

Advancements in Stem Cell Therapy for Nerve Repair & Regeneration to Bolster Nerve Repair & Regeneration Market Growth in South & Central America during Forecast Period

Cell-based therapy improves the functional clinical outcome after nerve injury. In recent years, the technology in constructing tissue-engineered nerve grafts has seen significant progress. Incorporating stem cells such as embryonic stem cells, neural stem cells, bone marrow mesenchymal stem cells, adipose stem cells, skin-derived precursor stem cells, and induced pluripotent stem cells have enhanced the therapeutic effects of tissue-engineered nerve grafts. The high effectiveness of stem cells enlightens the optimistic future of the large-scale clinical use of stem cells. Incorporating stem cells as seed cells into the biomaterial-based scaffolds increases the effectiveness of tissue-engineered nerve grafts and boosts the regenerative process. Numerous stem cells such as neural stem cells, embryonic stem cells, adipose stem cells, skin-derived precursor stem cells, induced pluripotent stem cells, and bone marrow mesenchymal stem cells have been used in neural tissue engineering. Cell-based therapy improves neural regeneration after peripheral nerve injuries (PNIs); it has introduced a new perspective to regenerative medicine. The main mechanisms that highlight the valuable effects of stem cells on neural regeneration are augmenting axonal regeneration, remyelination, and muscle mass preservation. Thus, the advancements in stem cell therapy for nerve repair & regeneration are likely to offer growth opportunities for the nerve repair & regeneration market players operating in South & Central America.

Market Overview

The South & Central America nerve repair & regeneration market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil accounted for a significant share of the market in 2021, followed by Argentina. The nerve repair & regeneration market in South & Central America is expected to grow due to the rising cases of Parkinson’s and Alzheimer’s diseases, a surge in the geriatric population, and a rising number of developments by various organizations in countries across the region.

South & Central America Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Nerve Repair & Regeneration Market Segmentation

The South & Central America nerve repair & regeneration market is bifurcated on the basis of product and application.

Based on product, the South & Central America nerve repair & regeneration market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment accounted for a larger market share in 2022. Based on application, the South & Central America nerve repair & regeneration market is bifurcated into neurostimulation & neuromodulation applications and nerve repair & regeneration applications. The nerve repair & regeneration applications segment held a larger market share in 2022. Based on country, the South & Central America nerve repair & regeneration market is segmented into Brazil, Argentina, and the Rest of South & Central America. Further, Brazil dominated the market in 2022. Axogen Corporation, Boston Scientific Corporation, Integra LifeSciences, Medtronic, Abbott Laboratories, Stryker Corporation, Neuronetics, LivaNova PLC, Baxter, and Polyganics BV are the leading companies operating in the nerve repair & regeneration market in South & Central America.

At 9.2% CAGR, the South & Central America Nerve Repair & Regeneration Market is speculated to be worth US$ 583.16 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the South & Central America nerve repair & Regeneration Market was valued at US$ 317.68 million in 2022 and is expected to reach US$ 583.16 million by 2028, registering a CAGR of 9.2% from 2022 to 2028. Increase in R&D activities and investment by market players and advances in stem cell therapy in nerve repair & regeneration are major factors boosting the growth of the market.

The importance of stem cells as crucial actors in the process of nerve regenerative is noticeable. Consequently, cell-based therapy became a significant and evidenced intervention that improves the functional clinical outcome after nerve injury. In recent years, the technology in constructing tissue-engineered nerve grafts has seen great progress. Incorporating stem cells, such as embryonic stem cells, neural stem cells, bone marrow mesenchymal stem cells, adipose stem cells, skin-derived precursor stem cells, and induced pluripotent stem cells have enhanced the therapeutic effects of tissue-engineered nerve grafts. The high effectiveness of stem cells enlightens the optimistic future of the large-scale clinical use of stem cells. Incorporating stem cells as seed cells into the biomaterial-based scaffolds increases the effectiveness of tissue-engineered nerve grafts and boosts the regenerative process. Numerous stem cells that include neural stem cells, embryonic stem cells, adipose stem cells, skin-derived precursor stem cells, induced pluripotent stem cells, and bone marrow mesenchymal stem cells, have been used in neural tissue engineering. Cell-based therapy for treating peripheral nerve injuries (PNIs) has brought a new perspective to regenerative medicine. Capability to differentiate into glial and neural cells, stem cells improve neural regeneration after PNIs. Augmenting axonal regeneration, remyelination, and muscle mass preservation are the main mechanisms underlying stem cells' valuable effects on neural regeneration. Thus, the advances in stem cell therapy in nerve repair & regeneration is likely to offer growth opportunities for the nerve repair & regeneration market players operating in this region.

On the contrary, dearth of trained professionals is acting as a market restraint.

Based on product type, the South & Central America nerve repair & regeneration market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation segment held 65.3% market share in 2022, amassing US$ 223.94 million. It is projected to garner US$ 377.69 million by 2028 to expand at 9.1% CAGR during 2022–2028.

Based on application, the South & Central America nerve repair & regeneration market is categorized into neurostimulation & neuromodulation applications and nerve repair & regeneration applications. The nerve repair & regeneration applications segment held 60.1% market share in 2022, amassing US$ 206.19 million. It is projected to garner US$ 347.52 million by 2028 to expand at 9.1% CAGR during 2022–2028.

Based on country, the South & Central America nerve repair & regeneration market has been segmented into Brazil, Argentina, and Rest of SAM. Our regional analysis states that Brazil captured 52.8% market share in 2022. It was assessed at US$ 181.02 million in 2022 and is likely to hit US$ 312.75 million by 2028, exhibiting a CAGR of 9.5% during the forecast period.

Key players dominating the South & Central America nerve repair & Regeneration Market are Axogen Corporation; Boston Scientific Corporation; Integra LifeSciences; Medtronic; Abbott Laboratories; Stryker Corporation; Neuronetics; LivaNova PLC; Baxter; and Polyganics BV among others.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 South & Central America Nerve Repair & Regeneration Market – By Product

1.3.1.1 Neurostimulation and Neuromodulation Devices

1.3.1.2 Biomaterials

1.3.2 South & Central America Nerve Repair & Regeneration Market – By Application

1.3.2.1 Neurostimulation & Neuromodulation Applications

1.3.2.2 Nerve Repair & Regeneration Applications

1.3.3 South & Central America Nerve Repair & Regeneration Market – By Country

2. South & Central America Nerve Repair & Regeneration Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Nerve Repair & Regeneration Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Experts Opinion

5. South & Central America Nerve Repair & Regeneration Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising incidence of nerve injuries and high prevalence of neurological disorders

5.1.2 Surging Funding by Private and Government Organizations for Research in Neurology

5.2 Key Market Restraints

5.2.1 Dearth of trained professionals

5.3 Key Market Opportunities

5.3.1 Advances in Stem Cell Therapy in Nerve Repair & Regeneration

5.4 Future Trend

5.4.1 Increase In R&D Activities and Investment by Market Players

5.5 Impact analysis

6. South & Central America Nerve Repair & Regeneration Market Analysis

6.1 South & Central America Nerve Repair & Regeneration Market Revenue Forecast and Analysis

7. South & Central America Nerve Repair & Regeneration Market – by Product

7.1 Overview

7.2 By Product: Market Revenue and Forecast Analysis (US$ Million)

7.2.1 Neurostimulation and Neuromodulation Devices

7.2.1.1 Overview

7.2.1.2 Neurostimulation and Neuromodulation Devices Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.3 Internal Neurostimulation Devices

7.2.1.3.1 Overview

7.2.1.3.2 Internal Neurostimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.3.3 Spinal Cord Stimulation

7.2.1.3.3.1 Overview

7.2.1.3.3.2 Spinal Cord Stimulation Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.3.4 Deep Brain Stimulation

7.2.1.3.4.1 Overview

7.2.1.3.4.2 Deep Brain Stimulation Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.3.5 Vagus Nerve Stimulation

7.2.1.3.5.1 Overview

7.2.1.3.5.2 Vagus Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.3.6 Sacral Nerve Stimulation

7.2.1.3.6.1 Overview

7.2.1.3.6.2 Sacral Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.3.7 Gastric Electrical Stimulation

7.2.1.3.7.1 Overview

7.2.1.3.7.2 Gastric Electrical Stimulation Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.4 External Neurostimulation Devices

7.2.1.4.1 Overview

7.2.1.4.2 External Neurostimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.4.3 Transcutaneous Electrical Nerve Stimulation Devices

7.2.1.4.3.1 Overview

7.2.1.4.3.2 Transcutaneous Electrical Nerve Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.4.4 Transcranial Magnetic Stimulation Devices

7.2.1.4.4.1 Overview

7.2.1.4.4.2 Transcranial Magnetic Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

7.2.1.4.5 Respiratory Electrical Stimulation Devices

7.2.1.4.5.1 Overview

7.2.1.4.5.2 Respiratory Electrical Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

7.2.2 Biomaterials

7.2.2.1 Overview

7.2.2.2 Biomaterials Market Revenue and Forecast to 2028 (US$ Million)

7.2.2.3 Nerve conduits

7.2.2.3.1 Overview

7.2.2.3.2 Nerve conduits Market Revenue and Forecast to 2028 (US$ Million)

7.2.2.4 Nerve wraps

7.2.2.4.1 Overview

7.2.2.4.2 Nerve wraps Market Revenue and Forecast to 2028 (US$ Million)

7.2.2.5 Nerve Connectors

7.2.2.5.1 Overview

7.2.2.5.2 Nerve Connectors Market Revenue and Forecast to 2028 (US$ Million)

7.2.2.6 Other Biomaterials

7.2.2.6.1 Overview

7.2.2.6.2 Other Biomaterials Market Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Nerve Repair & Regeneration Market - by Application

8.1 Overview

8.2 By Application: Market Revenue and Forecast Analysis (US$ Million)

8.2.1 Neurostimulation & Neuromodulation applications

8.2.1.1 Overview

8.2.1.2 Neurostimulation & Neuromodulation applications Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.3 Internal neurostimulation and neuromodulation

8.2.1.3.1 Overview

8.2.1.3.2 Internal neurostimulation and neuromodulation Market Revenue and Forecast to 2028 (US$ Million)

8.2.1.4 External neurostimulation and neuromodulation (LBL)

8.2.1.4.1 Overview

8.2.1.4.2 External neurostimulation and neuromodulation Market Revenue and Forecast to 2028 (US$ Million)

8.2.2 Nerve Repair & Regeneration Applications

8.2.2.1 Overview

8.2.2.2 Nerve Repair & Regeneration Applications Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.3 Direct Nerve Repair/Neurorrhaphy

8.2.2.3.1 Overview

8.2.2.3.2 Direct Nerve Repair/Neurorrhaphy Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.3.3 Epineural Repair

8.2.2.3.3.1 Overview

8.2.2.3.3.2 Epineural Repair Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.3.4 Perineural Repair

8.2.2.3.4.1 Overview

8.2.2.3.4.2 Perineural Repair Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.3.5 Group Fascicular Repair

8.2.2.3.5.1 Overview

8.2.2.3.5.2 Group Fascicular Repair Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.4 Nerve Grafting

8.2.2.4.1 Overview

8.2.2.4.2 Nerve Grafting Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.4.3 Autografts

8.2.2.4.3.1 Overview

8.2.2.4.3.2 Autografts Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.4.4 Allografts

8.2.2.4.4.1 Overview

8.2.2.4.4.2 Allografts Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.4.5 Xenografts

8.2.2.4.5.1 Overview

8.2.2.4.5.2 Xenografts Market Revenue and Forecast to 2028 (US$ Million)

8.2.2.5 Stem cell therapy

8.2.2.5.1 Overview

8.2.2.5.2 Stem cell therapy Market Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Nerve Repair & Regeneration Market – Country Analysis

9.1 Overview

9.1.1 South & Central America: Nerve Repair & Regeneration Market Revenue and Forecasts to 2028, By Country, 2021 & 2028 (%)

9.1.1.1 Brazil: Nerve Repair & Regeneration Market Revenue and Forecasts to 2028 (US$ Million)

9.1.1.1.1 Overview

9.1.1.1.2 Brazil: Nerve Repair & Regeneration Market Revenue and Forecasts to 2028 (US$ Million)

9.1.1.1.3 Brazil: Nerve Repair & Regeneration Market, By Product – 2019–2028 (US$ Million)

9.1.1.1.3.1 Brazil: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Devices – 2019–2028 (US$ Million)

9.1.1.1.3.2 Brazil: Nerve Repair & Regeneration Market, By Biomaterials– 2019–2028 (US$ Million)

9.1.1.1.4 Brazil: Nerve Repair & Regeneration Market, by Applications – 2019–2028 (US$ Million)

9.1.1.1.4.1 Brazil: Nerve Repair & Regeneration Market, By Neurostimulation & Neuromodulation Applications– 2019–2028 (US$ Million)

9.1.1.1.4.2 Brazil: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications – 2019–2028 (US$ Million)

9.1.1.2 Argentina: Nerve Repair & Regeneration Market Revenue and Forecasts to 2028 (US$ Million)

9.1.1.2.1 Overview

9.1.1.2.2 Argentina: Nerve Repair & Regeneration Market Revenue and Forecasts to 2028 (US$ Million)

9.1.1.2.3 Argentina: Nerve Repair & Regeneration Market, By Product – 2019–2028 (US$ Million)

9.1.1.2.3.1 Argentina: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Devices – 2019–2028 (US$ Million)

9.1.1.2.3.2 Argentina: Nerve Repair & Regeneration Market, By Biomaterials– 2019–2028 (US$ Million)

9.1.1.2.4 Argentina: Nerve Repair & Regeneration Market, by Applications – 2019–2028 (US$ Million)

9.1.1.2.4.1 Argentina: Nerve Repair & Regeneration Market, By Neurostimulation & Neuromodulation Applications– 2019–2028 (US$ Million)

9.1.1.2.4.2 Argentina: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications – 2019–2028 (US$ Million)

9.1.1.3 Rest of South & Central America Nerve Repair & Regeneration Market Revenue and Forecasts to 2028 (US$ Million)

9.1.1.3.1 Overview

9.1.1.3.2 Rest of South & Central America: Nerve Repair & Regeneration Market Revenue and Forecasts to 2028 (US$ Million)

9.1.1.3.3 Rest of South & Central America: Nerve Repair & Regeneration Market, By Product – 2019–2028 (US$ Million)

9.1.1.3.3.1 Rest of South & Central America: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Devices – 2019–2028 (US$ Million)

9.1.1.3.3.2 Rest of South & Central America: Nerve Repair & Regeneration Market, By Biomaterials– 2019–2028 (US$ Million)

9.1.1.3.4 Rest of South & Central America: Nerve Repair & Regeneration Market, by Applications – 2019–2028 (US$ Million)

9.1.1.3.4.1 Rest of South & Central America: Nerve Repair & Regeneration Market, By Neurostimulation & Neuromodulation Applications– 2019–2028 (US$ Million)

9.1.1.3.4.2 Rest of South & Central America: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications – 2019–2028 (US$ Million)

10. South & Central America Nerve Repair & Regeneration Market – Industry Landscape

10.1 Overview

10.2 Inorganic Growth Strategies

10.2.1 Overview

10.3 Organic Growth Strategies

10.3.1 Overview

11. Company Profiles

11.1 Axogen Corporation

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Boston Scientific Corporation

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Integra LifeSciences

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Medtronic

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Abbott Laboratories

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Stryker Corporation

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Neuronetics

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 LivaNova PLC

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Baxter

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Polyganics BV

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

Table 1.             Brazil: Nerve Repair & Regeneration Market, by Product – Revenue and Forecast to 2028 (US$ Million).

Table 2.             Brazil: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Devices – Revenue and Forecast to 2028  (US$ Million)

Table 3.             Brazil: Nerve Repair & Regeneration Market, by Internal Neurostimulation Devices – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Brazil: Nerve Repair & Regeneration Market, by External Neurostimulation Devices – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Brazil: Nerve Repair & Regeneration Market, by Biomaterials– Revenue and Forecast to 2028 (US$ Million).

Table 6.             Brazil: Nerve Repair & Regeneration Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 7.             Brazil: Nerve Repair & Regeneration Market, by Neurostimulation & Neuromodulation Applications – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Brazil: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Brazil: Nerve Repair & Regeneration Market, by Direct Nerve Repair/Neurorrhaphy – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Brazil: Nerve Repair & Regeneration Market, by Nerve Grafting – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Argentina: Nerve Repair & Regeneration Market, by Product – Revenue and Forecast to 2028 (US$ Million).

Table 12.          Argentina: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Devices – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Argentina: Nerve Repair & Regeneration Market, by Internal Neurostimulation Devices – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Argentina: Nerve Repair & Regeneration Market, by External Neurostimulation Devices – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Argentina: Nerve Repair & Regeneration Market, by Biomaterials– Revenue and Forecast to 2028 (US$ Million).

Table 16.          Argentina: Nerve Repair & Regeneration Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 17.          Argentina: Nerve Repair & Regeneration Market, by Neurostimulation & Neuromodulation Applications – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Argentina: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Argentina: Nerve Repair & Regeneration Market, by Direct Nerve Repair/Neurorrhaphy – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Argentina: Nerve Repair & Regeneration Market, by Nerve Grafting – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Rest of South & Central America: Nerve Repair & Regeneration Market, by Product – Revenue and Forecast to 2028 (US$ Million).

Table 22.          Rest of South & Central America: Nerve Repair & Regeneration Market, by Neurostimulation and Neuromodulation Devices – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Rest of South & Central America: Nerve Repair & Regeneration Market, by Internal Neurostimulation Devices – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Rest of South & Central America: Nerve Repair & Regeneration Market, by External Neurostimulation Devices – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Rest of South & Central America: Nerve Repair & Regeneration Market, by Biomaterials– Revenue and Forecast to 2028 (US$ Million).

Table 26.          Rest of South & Central America: Nerve Repair & Regeneration Market, by Applications– Revenue and Forecast to 2028 (US$ Million)

Table 27.          Rest of South & Central America: Nerve Repair & Regeneration Market, by Neurostimulation & Neuromodulation Applications – Revenue and Forecast to 2028 (US$ Million)

Table 28.          Rest of South & Central America: Nerve Repair & Regeneration Market, by Nerve Repair & Regeneration Applications – Revenue and Forecast to 2028 (US$ Million)

Table 29.          Rest of South & Central America: Nerve Repair & Regeneration Market, by Direct Nerve Repair/Neurorrhaphy – Revenue and Forecast to 2028 (US$ Million)

Table 30.          Rest of South & Central America: Nerve Repair & Regeneration Market, by Nerve Grafting – Revenue and Forecast to 2028 (US$ Million)

Table 31.          Recent Inorganic Growth Strategies in the Nerve Repair & Regeneration Market

Table 32.          Recent Organic Growth Strategies in the Nerve Repair & Regeneration Market

Table 33.          Glossary of Terms

Figure 1.           South & Central America Nerve Repair & Regeneration Market Segmentation

Figure 2.           South & Central America Nerve Repair & Regeneration Market – By Country

Figure 3.           South & Central America Nerve Repair & Regeneration Market Overview

Figure 4.           Table Top Nerve Repair & Regenerations Held Largest Share by Product of Nerve Repair & Regeneration Market

Figure 5.           Brazil to Show Significant Growth During Forecast Period

Figure 6.           South & Central America Nerve Repair & Regeneration Market, Industry Landscape

Figure 7.           South & Central America: PEST Analysis

Figure 8.           Experts Opinion

Figure 9.           South & Central America Nerve Repair & Regeneration market impact analysis of driver and restraints

Figure 10.        South & Central America Nerve Repair & Regeneration Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 11.        By Product: Market Analysis and Forecast 2021 and 2028 (%)

Figure 12.        Neurostimulation and Neuromodulation Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Internal Neurostimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Spinal Cord Stimulation Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Deep Brain Stimulation Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Vagus Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Sacral Nerve Stimulation Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Gastric Electrical Stimulation Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        External Neurostimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Transcutaneous Electrical Nerve Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Transcranial Magnetic Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Respiratory Electrical Stimulation Devices Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Biomaterials Market Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Nerve conduits Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Nerve wraps Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Nerve Connectors Market Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Other Biomaterials Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        By Application: Market Analysis and Forecast 2021 and 2028 (%)

Figure 29.        Neurostimulation & Neuromodulation applications Market Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Internal neurostimulation and neuromodulation Market Revenue and Forecast to 2028 (US$ Million)

Figure 31.        External neurostimulation and neuromodulation Market Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Nerve Repair & Regeneration Applications Market Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Direct Nerve Repair/Neurorrhaphy Market Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Epineural Repair Market Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Perineural Repair Market Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Group Fascicular Repair Market Revenue and Forecast to 2028 (US$ Million)

Figure 37.        Nerve Grafting Market Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Autografts Market Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Allografts Market Revenue and Forecast to 2028 (US$ Million)

Figure 40.        Xenografts Market Revenue and Forecast to 2028 (US$ Million)

Figure 41.        Stem cell therapy Market Revenue and Forecast to 2028 (US$ Million)

Figure 42.        South & Central America Nerve Repair & Regeneration Market Overview, by Country (2021)

Figure 43.        South & Central America: Nerve Repair & Regeneration Market Revenue and Forecasts to 2028, By Country, 2021 & 2028 (%)

Figure 44.        Brazil: Nerve Repair & Regeneration Market Revenue and Forecasts to 2028 (US$ Million)

Figure 45.        Argentina: Nerve Repair & Regeneration Market Revenue and Forecasts to 2028 (US$ Million)

Figure 46.        Rest of South & Central America: Nerve Repair & Regeneration Market Revenue and Forecasts to 2028 (US$ Million)

● Axogen Corporation

● Boston Scientific Corporation      

● Integra LifeSciences

● Medtronic

● Abbott Laboratories

● Stryker Corporation

● Neuronetics

● LivaNova PLC

● Baxter

● Polyganics BV

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America nerve repair & regeneration market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the South & Central America nerve repair & regeneration market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the nerve repair & regeneration market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP